TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16434522

Group type: EXPERIMENTAL
Intervention: Acrobot system
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 27
Study: 12616257

Group type: EXPERIMENTAL
Intervention: Soy-enhanced lunches
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional lunches
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soy-enhanced foods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional and soy-enhanced lunches
Number of subjects: 0
Study: 10700598

Group type: EXPERIMENTAL
Intervention: Dementia of Alzheimer type (DAT)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Vascular dementia (VD)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Non-demented (ND)
Number of subjects: 115
Study: 9089127

Group type: EXPERIMENTAL
Intervention: Clinician-facilitated intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: Lecture-group discussion intervention
Number of subjects: 37
Study: 8447521

Group type: EXPERIMENTAL
Intervention: 300 micrograms/kg of ivermectin
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 400 micrograms/kg of ivermectin
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both doses (300 and 400 micrograms/kg)
Number of subjects: 31
Study: 3640743

Group type: EXPERIMENTAL
Intervention: Single-bagging
Number of subjects: 42

Group type: COMPARATOR
Intervention: Double-bagging
Number of subjects: 42
Study: 31722475

Group type: EXPERIMENTAL
Intervention: Simulation-based Policy Optimization with Transferability Assessment (SPOTA)
Number of subjects: 0
Study: 31282129

Group type: EXPERIMENTAL
Intervention: UFR-guided hydration with normal saline plus low-dose furosemide controlled by the RenalGuard system to maintain a high urine flow rate (>300 mL/hr)
Number of subjects: 700

Group type: COMPARATOR
Intervention: LVEDP-guided hydration with normal saline adjusted according to LVEDP levels (5 mL kg-1 hr-1 for LVEDP ≤12 mmHg, 3 mL kg-1 hr-1 for LVEDP 13-18 mmHg, and 1.5 mL kg-1 hr-1 for LVEDP >18 mmHg)
Number of subjects: 700
Study: 30218248

Group type: EXPERIMENTAL
Intervention: Robotic right colectomy
Number of subjects: 202

Group type: COMPARATOR
Intervention: Laparoscopic right colectomy
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Robotic right colectomy (UICC stage III)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Laparoscopic right colectomy (UICC stage III)
Number of subjects: 202
Study: 27264220

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3×/wk, 35 min, 70%-85% VO2peak)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Escitalopram (5-20 mg qd)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Aerobic exercise, Escitalopram, and Placebo
Number of subjects: 150
Study: 24249843

Group type: EXPERIMENTAL
Intervention: Novel augmented core stabilization exercise technique (ankle dorsiflexion + drawing in abdominal wall)
Number of subjects: 40
Study: 22585691

Group type: EXPERIMENTAL
Intervention: Adjuvant radiochemotherapy (Fluorouracil and leucovorin before, during, and after radiotherapy; Radiotherapy dose of 45 Gy)
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Adjuvant radiochemotherapy
Number of subjects: 559

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 559
Study: 20133510

Group type: EXPERIMENTAL
Intervention: Ketoprofen patch (20 mg, once daily for 2 weeks)
Number of subjects: 676

Group type: COMPARATOR
Intervention: Placebo patch (once daily for 2 weeks)
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Ketoprofen patch
Number of subjects: 676

Group type: COMPARATOR
Intervention: Ketoprofen patch and Placebo patch
Number of subjects: 676
Study: 18780127

Group type: EXPERIMENTAL
Intervention: Physicians with higher dutifulness
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Physicians with higher vulnerability
Number of subjects: 46
Study: 15937906

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Radiotherapy combined with carbogen breathing
Number of subjects: 101
Study: 12627514

Group type: EXPERIMENTAL
Intervention: Tumor mitotic rate (TMR) of 0 mitoses/mm(2)
Number of subjects: 3661

Group type: EXPERIMENTAL
Intervention: Tumor mitotic rate (TMR) of 1 mitosis/mm(2)
Number of subjects: 3661

Group type: EXPERIMENTAL
Intervention: TMR grouped using Method A (0, 1-4, 5-10, and >/= 11 mitoses/mm(2))
Number of subjects: 3661
Study: 10028219

Group type: EXPERIMENTAL
Intervention: 10-week school-based child- and parent-focused psychosocial intervention
Number of subjects: 128

Group type: COMPARATOR
Intervention: Monitoring group
Number of subjects: 128
Study: 8721529

Group type: EXPERIMENTAL
Intervention: 20% ethanol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 14
Study: 2057176

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Interferon alpha
Number of subjects: 593

Group type: COMPARATOR
Intervention: Busulfan
Number of subjects: 593
Study: 6338610

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (metronidazole and cephradine) given preoperatively
Number of subjects: 202

Group type: COMPARATOR
Intervention: Antibiotics given at operation only upon finding perforation, gangrene or pus formation
Number of subjects: 202
Study: 29511966

Group type: COMPARATOR
Intervention: Integrated PFI
Number of subjects: 402

Group type: COMPARATOR
Intervention: Combined PFI
Number of subjects: 402
Study: 30100904

Group type: EXPERIMENTAL
Intervention: iBCE-EL (ensemble learning framework combining ERT and GB classifiers)
Number of subjects: 11543

Group type: COMPARATOR
Intervention: Individual classifiers (ERT and GB)
Number of subjects: 11543
Study: 26879651

Group type: EXPERIMENTAL
Intervention: Docetaxel plus cisplatin (DP arm)
Number of subjects: 2

Group type: COMPARATOR
Intervention: TS-1 plus cisplatin (SP arm)
Number of subjects: 2
Study: 24867298

Group type: EXPERIMENTAL
Intervention: Pregabalin CR (330-495 mg/day)
Number of subjects: 441

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Pregabalin CR
Number of subjects: 441
Study: 23092336

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) - ten sessions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 50
Study: 20175941

Group type: EXPERIMENTAL
Intervention: quetiapine XR 300 mg/d
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: quetiapine XR 150 mg/d
Number of subjects: 446

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 446
Study: 17598895

Group type: EXPERIMENTAL
Intervention: Telecare service provided by a Diabetes Specialist Nurse (DSN)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Telecare service provided by a peer supporter
Number of subjects: 375

Group type: COMPARATOR
Intervention: Routine care only (Control)
Number of subjects: 375
Study: 15613570

Group type: EXPERIMENTAL
Intervention: Etamsylate 12.5 mg/kg six hourly from within one hour of delivery for four days
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 12440799

Group type: EXPERIMENTAL
Intervention: Increased intensity of therapy (67% more therapy per week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard therapy intensity)
Number of subjects: 0
Study: 10530655

Group type: EXPERIMENTAL
Intervention: IV EtOH (10% solution administered over 30 minutes)
Number of subjects: 20

Group type: COMPARATOR
Intervention: PO EtOH (20% solution in juice administered over 10 minutes)
Number of subjects: 20
Study: 7548380

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment started during operation (Cefuroxime and Tinidazole)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Antibiotic treatment started before operation (Cefuroxime and Tinidazole)
Number of subjects: 234
Study: 1971590

Group type: EXPERIMENTAL
Intervention: Xamoterol 0.2 mg kg‐1 i.v.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 91482

Group type: EXPERIMENTAL
Intervention: Brief acoustic stimuli at 70 dB SPL presented at various intervals (5 to 800 msec) prior to the eliciting stimulus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Similar stimuli with intensities varying from 30 to 70 dB SPL at a fixed lead time of 100 msec
Number of subjects: 0
Study: 31711093

Group type: EXPERIMENTAL
Intervention: PC1 (negative loadings on uncultured Christensenellaceae and Ruminococcaceae)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: PC2 (positive loadings on Fusicatenibacter and Bifidobacterium; negative loadings on Bacteroides)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: PC3 (positive loadings on Faecalibacterium, Eubacterium, and Roseburia)
Number of subjects: 319
Study: 31852699

Group type: EXPERIMENTAL
Intervention: POCT using the FilmArray respiratory panel
Number of subjects: 840

Group type: COMPARATOR
Intervention: Routine clinical care
Number of subjects: 840
Study: 28575331

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT) guided by oesophageal Doppler monitoring
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard haemodynamic management (control group)
Number of subjects: 100
Study: 24247999

Group type: EXPERIMENTAL
Intervention: Ex‐PRESS shunt with mitomycin-C
Number of subjects: 64

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin-C
Number of subjects: 64
Study: 23482600

Group type: EXPERIMENTAL
Intervention: Thigh-length graduated compression stockings (Trial 1)
Number of subjects: 5532

Group type: EXPERIMENTAL
Intervention: Thigh-length graduated compression stockings (Trial 2)
Number of subjects: 5532

Group type: COMPARATOR
Intervention: Below-knee graduated compression stockings (Trial 2)
Number of subjects: 5532
Study: 21491012

Group type: EXPERIMENTAL
Intervention: Connective tissue graft (CTG) + enamel matrix derivative (EMD)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Connective tissue graft (CTG) alone
Number of subjects: 56
Study: 19622153

Group type: EXPERIMENTAL
Intervention: Urodynamic evaluation followed by operative therapy
Number of subjects: 600

Group type: COMPARATOR
Intervention: Urodynamic evaluation followed by individually tailored therapy
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Urodynamic evaluation
Number of subjects: 600
Study: 17106179

Group type: EXPERIMENTAL
Intervention: Colestimide
Number of subjects: 33

Group type: COMPARATOR
Intervention: Acarbose
Number of subjects: 33
Study: 15242431

Group type: EXPERIMENTAL
Intervention: 1 g of an ordinary paracetamol tablet
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 2 g of an ordinary paracetamol tablet
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 1 g of a bicarbonate paracetamol tablet
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 2 g of a bicarbonate paracetamol tablet
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 2 g intravenously of prodrug propacetamol
Number of subjects: 35
Study: 12072872

Group type: EXPERIMENTAL
Intervention: High frequency oscillatory ventilation (HFOV)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 19
Study: 10321438

Group type: EXPERIMENTAL
Intervention: Computer-based clinical decision support system (CDSS)
Number of subjects: 2239

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2239
Study: 7634866

Group type: EXPERIMENTAL
Intervention: Intravenous propafenone (2‐mg/kg bolus followed by 0.0078 mg/kg/min)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Oral propafenone (600 mg orally single dose)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 2612238

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 40
Study: 674351

Group type: EXPERIMENTAL
Intervention: Imipramine (100 mg orally)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lofepramine (140 mg orally)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31776604

Group type: EXPERIMENTAL
Intervention: Scarpa's fascia preservation during abdominoplasty (n=21)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fascia dissection during abdominoplasty (n=21)
Number of subjects: 42
Study: 31688812

Group type: EXPERIMENTAL
Intervention: Lower glucose target group
Number of subjects: 698

Group type: COMPARATOR
Intervention: Higher glucose target group
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: New or progressive multiple organ dysfunction syndrome
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Progressive multiple organ dysfunction syndrome
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Recurrent multiple organ dysfunction syndrome
Number of subjects: 698
Study: 27984466

Group type: EXPERIMENTAL
Intervention: Combined strength and endurance training program for 70 minutes per day, 3 days per week, for 8 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no exercise program)
Number of subjects: 15
Study: 26992303

Group type: EXPERIMENTAL
Intervention: Polidocanol endovenous microfoam 1%
Number of subjects: 221
Study: 23818410

Group type: EXPERIMENTAL
Intervention: Mini-trampoline group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40
Study: 21854285

Group type: EXPERIMENTAL
Intervention: Screening, brief intervention, and referral to treatment model in medical EDs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 20146894

Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg loading dose followed by 200 mg twice daily)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Non-selective NSAIDs (standard doses)
Number of subjects: 278
Study: 17309762

Group type: EXPERIMENTAL
Intervention: Warm dialysate condition (37 degrees C)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Cool dialysate condition (35 degrees C)
Number of subjects: 7
Study: 14762409

Group type: EXPERIMENTAL
Intervention: Cataract extraction with acrylic intraocular lens implantation
Number of subjects: 49
Study: 11431647

Group type: EXPERIMENTAL
Intervention: Intravaginal Crinone, 90 mg/day (n=51)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Intramuscular Prontogest, 50 mg/day (n=48)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Intravaginal Crinone, 90 mg/day
Number of subjects: 99

Group type: COMPARATOR
Intervention: Intramuscular Prontogest, 50 mg/day
Number of subjects: 99
Study: 9506875

Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Meloxicam 15 mg
Number of subjects: 513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Meloxicam 30 mg
Number of subjects: 513
Study: 29986745

Group type: EXPERIMENTAL
Intervention: 8 weeks of aerobic exercise with targeted intensity
Number of subjects: 40

Group type: COMPARATOR
Intervention: 8 weeks of leisure exercise
Number of subjects: 40
Study: 28799823

Group type: COMPARATOR
Intervention: 2'-O-Methoxyethyl-modified antisense oligonucleotides (ASOs) administered at doses ranging from 50 to 450 mg via subcutaneous injection and up to 600 mg via intravenous infusion
Number of subjects: 10
Study: 25748671

Group type: EXPERIMENTAL
Intervention: 100% ethanol for 60 s before application of Single Bond 2
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Distilled water for 60 s before application of Single Bond 2
Number of subjects: 17

Group type: COMPARATOR
Intervention: Calcium hydroxide lining before etching and bonding (control)
Number of subjects: 17
Study: 24130362

Group type: EXPERIMENTAL
Intervention: 10-s maximal sprint after moderate-intensity exercise
Number of subjects: 7

Group type: COMPARATOR
Intervention: Moderate-intensity exercise alone
Number of subjects: 7
Study: 19823051

Group type: EXPERIMENTAL
Intervention: Bivalent HPV vaccine (Cervarix)
Number of subjects: 47236

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine (Gardasil)
Number of subjects: 47236

Group type: COMPARATOR
Intervention: Bivalent and Quadrivalent HPV vaccines
Number of subjects: 47236
Study: 17540225

Group type: EXPERIMENTAL
Intervention: Somatization disorder patients
Number of subjects: 70

Group type: COMPARATOR
Intervention: Mood and/or anxiety disorder patients (controls)
Number of subjects: 70
Study: 15449353

Group type: EXPERIMENTAL
Intervention: Surprised faces
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral or disgust expressions
Number of subjects: 0
Study: 11680648

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Applied relaxation
Number of subjects: 65

Group type: COMPARATOR
Intervention: Nitrous oxide sedation (control)
Number of subjects: 65
Study: 9694550

Group type: EXPERIMENTAL
Intervention: Pravastatin (36.64 mg daily for 3 years)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 7807754

Group type: EXPERIMENTAL
Intervention: B + S
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: B + R
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: B alone
Number of subjects: 94
Study: 2772858

Group type: EXPERIMENTAL
Intervention: Allergen inhalation challenge
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phosphate buffered saline (control solution)
Number of subjects: 0
Study: 17374

Group type: EXPERIMENTAL
Intervention: Metyrosine (administered for three weeks)
Number of subjects: 0
Study: 31883218

Group type: EXPERIMENTAL
Intervention: Processed/snacking dietary pattern
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: African/Caribbean dietary pattern
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Healthy/prudent dietary pattern
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Lower enjoyment of food and food responsiveness
Number of subjects: 482
Study: 31387121

Group type: EXPERIMENTAL
Intervention: Menaquinone-7 (MK-7) 360 µg/d for 6 months
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 68
Study: 27778191

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 1800 mg/day
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control (statin therapy only)
Number of subjects: 106
Study: 24833246

Group type: EXPERIMENTAL
Intervention: Laparoendoscopic single-site surgery (LESS)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional laparoscopic surgery
Number of subjects: 35
Study: 23582440

Group type: EXPERIMENTAL
Intervention: Fibered microcoils
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Detachable hydrogel-coated microcoils
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pushable hydrogel-coated microcoils
Number of subjects: 43
Study: 21491073

Group type: EXPERIMENTAL
Intervention: 4-week inpatient rehabilitation programme in a Mediterranean setting
Number of subjects: 107

Group type: COMPARATOR
Intervention: 4-week inpatient rehabilitation programme in a Norwegian setting
Number of subjects: 107
Study: 19423098

Group type: EXPERIMENTAL
Intervention: Gelatin-thrombin matrix (FloSeal Matrix)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study: 17343981

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 15533478

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical nephrectomy (LRN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Retroperitoneoscopic radical nephrectomy (RRN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Robotic assistance system (AESOP) with RRN
Number of subjects: 40
Study: 11808544

Group type: EXPERIMENTAL
Intervention: Raloxifene therapy
Number of subjects: 2622
Study: 10021954

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5%
Number of subjects: 61

Group type: COMPARATOR
Intervention: Bupivacaine 0.5%
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 61
Study: 7541310

Group type: EXPERIMENTAL
Intervention: Hydromorphone (1 mg IV)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Meperidine (50 mg IV)
Number of subjects: 73
Study: 3071325

Group type: EXPERIMENTAL
Intervention: 45-min exercise (50% of VO2 max) with real field exposure (9-kV/m, 16-A/m)
Number of subjects: 11

Group type: COMPARATOR
Intervention: 45-min exercise (50% of VO2 max) with sham exposure
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: No-exercise sessions with real field exposure (9-kV/m, 16-A/m)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No-exercise sessions with sham exposure
Number of subjects: 11
Study: 31341133

Group type: EXPERIMENTAL
Intervention: Intraoperative predonated blood transfusion (group A)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (group N)
Number of subjects: 53
Study: 27613946

Group type: EXPERIMENTAL
Intervention: Vigorous intensity supervised exercise (EX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Women who smoked
Number of subjects: 30
Study: 25819856

Group type: EXPERIMENTAL
Intervention: Mental stress-induced myocardial ischemia (MSIMI) group
Number of subjects: 270

Group type: COMPARATOR
Intervention: Normal left ventricular response to stress (NLVR) group
Number of subjects: 270

Group type: COMPARATOR
Intervention: MSIMI group vs NLVR group
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Resting platelet aggregation and serotonin transporter expression
Number of subjects: 270
Study: 24015715

Group type: EXPERIMENTAL
Intervention: Biscuits (low glycemic index, high slowly available glucose)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Extruded cereals (medium GI, low SAG)
Number of subjects: 25
Study: 21871144

Group type: EXPERIMENTAL
Intervention: Probiotic fruit yoghurt 'mild' containing Lactobacillus acidophilus LA-5 plus Bifidobacterium lactis BB-12 (n=30)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Pasteurized probiotic fruit yoghurt (n=29)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Milk acidified with lactic acid (control, n=29)
Number of subjects: 88
Study: 18770043

Group type: EXPERIMENTAL
Intervention: Consistently high spirituality group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing spirituality group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Consistently low spirituality group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreasing spirituality group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Religiosity groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spirituality group membership
Number of subjects: 0

Group type: COMPARATOR
Intervention: Religiosity group membership
Number of subjects: 0
Study: 17362457

Group type: EXPERIMENTAL
Intervention: Acrysof Natural IOL
Number of subjects: 93